Last reviewed · How we verify
Prostagladin
At a glance
| Generic name | Prostagladin |
|---|---|
| Also known as | B-Blocker, Carbonic anydrase inhibitor |
| Sponsor | Nova Scotia Health Authority |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Laser in Pseudoexfoliation (LIP) Study (PHASE4)
- Correlation Between Early Induction of Labor and Cesarean Delivery in Low-risk Nulliparous Women
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |